0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Mesalazine Enteric Coated Tablets Market Research Report 2024
Published Date: August 2024
|
Report Code: QYRE-Auto-14C18094
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Mesalazine Enteric Coated Tablets Market Research Report 2024
BUY CHAPTERS

Global Mesalazine Enteric Coated Tablets Market Research Report 2024

Code: QYRE-Auto-14C18094
Report
August 2024
Pages:83
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Mesalazine Enteric Coated Tablets Market

The global Mesalazine Enteric Coated Tablets market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Mesalazine Enteric Coated Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Mesalazine Enteric Coated Tablets is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Mesalazine Enteric Coated Tablets include Dr. Falk Pharma GmbH, Astellas Pharma Inc., AbbVie Inc., DSM Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Fosun Pharma, Huahai Pharmaceuticals, UCB Pharma, CR Sanjiu, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Mesalazine Enteric Coated Tablets, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalazine Enteric Coated Tablets.
The Mesalazine Enteric Coated Tablets market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Mesalazine Enteric Coated Tablets market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Mesalazine Enteric Coated Tablets manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Mesalazine Enteric Coated Tablets Market Report

Report Metric Details
Report Name Mesalazine Enteric Coated Tablets Market
Segment by Type
  • 0.25g
  • 0.5g
  • 1g
Segment by Application
  • Hospital
  • Clinic
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Dr. Falk Pharma GmbH, Astellas Pharma Inc., AbbVie Inc., DSM Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Fosun Pharma, Huahai Pharmaceuticals, UCB Pharma, CR Sanjiu
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Mesalazine Enteric Coated Tablets manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Mesalazine Enteric Coated Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Mesalazine Enteric Coated Tablets Market report?

Ans: The main players in the Mesalazine Enteric Coated Tablets Market are Dr. Falk Pharma GmbH, Astellas Pharma Inc., AbbVie Inc., DSM Pharmaceuticals, Sun Pharmaceutical Industries Ltd., Fosun Pharma, Huahai Pharmaceuticals, UCB Pharma, CR Sanjiu

What are the Application segmentation covered in the Mesalazine Enteric Coated Tablets Market report?

Ans: The Applications covered in the Mesalazine Enteric Coated Tablets Market report are Hospital, Clinic, Others

What are the Type segmentation covered in the Mesalazine Enteric Coated Tablets Market report?

Ans: The Types covered in the Mesalazine Enteric Coated Tablets Market report are 0.25g, 0.5g, 1g

Recommended Reports

Bowel Disease Therapeutics

Pharmaceutical Coating

Digestive & GI Drugs

1 Mesalazine Enteric Coated Tablets Market Overview
1.1 Product Definition
1.2 Mesalazine Enteric Coated Tablets by Type
1.2.1 Global Mesalazine Enteric Coated Tablets Market Value Comparison by Type (2024-2030)
1.2.2 0.25g
1.2.3 0.5g
1.2.4 1g
1.3 Mesalazine Enteric Coated Tablets by Application
1.3.1 Global Mesalazine Enteric Coated Tablets Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Mesalazine Enteric Coated Tablets Market Size Estimates and Forecasts
1.4.1 Global Mesalazine Enteric Coated Tablets Revenue 2019-2030
1.4.2 Global Mesalazine Enteric Coated Tablets Sales 2019-2030
1.4.3 Global Mesalazine Enteric Coated Tablets Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Mesalazine Enteric Coated Tablets Market Competition by Manufacturers
2.1 Global Mesalazine Enteric Coated Tablets Sales Market Share by Manufacturers (2019-2024)
2.2 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Mesalazine Enteric Coated Tablets Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of Mesalazine Enteric Coated Tablets, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Product Type & Application
2.7 Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Date of Enter into This Industry
2.8 Global Mesalazine Enteric Coated Tablets Market Competitive Situation and Trends
2.8.1 Global Mesalazine Enteric Coated Tablets Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Mesalazine Enteric Coated Tablets Players Market Share by Revenue
2.8.3 Global Mesalazine Enteric Coated Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Mesalazine Enteric Coated Tablets Market Scenario by Region
3.1 Global Mesalazine Enteric Coated Tablets Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Mesalazine Enteric Coated Tablets Sales by Region: 2019-2030
3.2.1 Global Mesalazine Enteric Coated Tablets Sales by Region: 2019-2024
3.2.2 Global Mesalazine Enteric Coated Tablets Sales by Region: 2025-2030
3.3 Global Mesalazine Enteric Coated Tablets Revenue by Region: 2019-2030
3.3.1 Global Mesalazine Enteric Coated Tablets Revenue by Region: 2019-2024
3.3.2 Global Mesalazine Enteric Coated Tablets Revenue by Region: 2025-2030
3.4 North America Mesalazine Enteric Coated Tablets Market Facts & Figures by Country
3.4.1 North America Mesalazine Enteric Coated Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Mesalazine Enteric Coated Tablets Sales by Country (2019-2030)
3.4.3 North America Mesalazine Enteric Coated Tablets Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Mesalazine Enteric Coated Tablets Market Facts & Figures by Country
3.5.1 Europe Mesalazine Enteric Coated Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Mesalazine Enteric Coated Tablets Sales by Country (2019-2030)
3.5.3 Europe Mesalazine Enteric Coated Tablets Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Mesalazine Enteric Coated Tablets Market Facts & Figures by Region
3.6.1 Asia Pacific Mesalazine Enteric Coated Tablets Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Mesalazine Enteric Coated Tablets Sales by Region (2019-2030)
3.6.3 Asia Pacific Mesalazine Enteric Coated Tablets Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Mesalazine Enteric Coated Tablets Market Facts & Figures by Country
3.7.1 Latin America Mesalazine Enteric Coated Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Mesalazine Enteric Coated Tablets Sales by Country (2019-2030)
3.7.3 Latin America Mesalazine Enteric Coated Tablets Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Mesalazine Enteric Coated Tablets Market Facts & Figures by Country
3.8.1 Middle East and Africa Mesalazine Enteric Coated Tablets Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Mesalazine Enteric Coated Tablets Sales by Country (2019-2030)
3.8.3 Middle East and Africa Mesalazine Enteric Coated Tablets Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Mesalazine Enteric Coated Tablets Sales by Type (2019-2030)
4.1.1 Global Mesalazine Enteric Coated Tablets Sales by Type (2019-2024)
4.1.2 Global Mesalazine Enteric Coated Tablets Sales by Type (2025-2030)
4.1.3 Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2019-2030)
4.2 Global Mesalazine Enteric Coated Tablets Revenue by Type (2019-2030)
4.2.1 Global Mesalazine Enteric Coated Tablets Revenue by Type (2019-2024)
4.2.2 Global Mesalazine Enteric Coated Tablets Revenue by Type (2025-2030)
4.2.3 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2019-2030)
4.3 Global Mesalazine Enteric Coated Tablets Price by Type (2019-2030)
5 Segment by Application
5.1 Global Mesalazine Enteric Coated Tablets Sales by Application (2019-2030)
5.1.1 Global Mesalazine Enteric Coated Tablets Sales by Application (2019-2024)
5.1.2 Global Mesalazine Enteric Coated Tablets Sales by Application (2025-2030)
5.1.3 Global Mesalazine Enteric Coated Tablets Sales Market Share by Application (2019-2030)
5.2 Global Mesalazine Enteric Coated Tablets Revenue by Application (2019-2030)
5.2.1 Global Mesalazine Enteric Coated Tablets Revenue by Application (2019-2024)
5.2.2 Global Mesalazine Enteric Coated Tablets Revenue by Application (2025-2030)
5.2.3 Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2019-2030)
5.3 Global Mesalazine Enteric Coated Tablets Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Dr. Falk Pharma GmbH
6.1.1 Dr. Falk Pharma GmbH Company Information
6.1.2 Dr. Falk Pharma GmbH Description and Business Overview
6.1.3 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product Portfolio
6.1.5 Dr. Falk Pharma GmbH Recent Developments/Updates
6.2 Astellas Pharma Inc.
6.2.1 Astellas Pharma Inc. Company Information
6.2.2 Astellas Pharma Inc. Description and Business Overview
6.2.3 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product Portfolio
6.2.5 Astellas Pharma Inc. Recent Developments/Updates
6.3 AbbVie Inc.
6.3.1 AbbVie Inc. Company Information
6.3.2 AbbVie Inc. Description and Business Overview
6.3.3 AbbVie Inc. Mesalazine Enteric Coated Tablets Sales, Revenue and Gross Margin (2019-2024)
6.3.4 AbbVie Inc. Mesalazine Enteric Coated Tablets Product Portfolio
6.3.5 AbbVie Inc. Recent Developments/Updates
6.4 DSM Pharmaceuticals
6.4.1 DSM Pharmaceuticals Company Information
6.4.2 DSM Pharmaceuticals Description and Business Overview
6.4.3 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Revenue and Gross Margin (2019-2024)
6.4.4 DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio
6.4.5 DSM Pharmaceuticals Recent Developments/Updates
6.5 Sun Pharmaceutical Industries Ltd.
6.5.1 Sun Pharmaceutical Industries Ltd. Company Information
6.5.2 Sun Pharmaceutical Industries Ltd. Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product Portfolio
6.5.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
6.6 Fosun Pharma
6.6.1 Fosun Pharma Company Information
6.6.2 Fosun Pharma Description and Business Overview
6.6.3 Fosun Pharma Mesalazine Enteric Coated Tablets Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Fosun Pharma Mesalazine Enteric Coated Tablets Product Portfolio
6.6.5 Fosun Pharma Recent Developments/Updates
6.7 Huahai Pharmaceuticals
6.7.1 Huahai Pharmaceuticals Company Information
6.7.2 Huahai Pharmaceuticals Description and Business Overview
6.7.3 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product Portfolio
6.7.5 Huahai Pharmaceuticals Recent Developments/Updates
6.8 UCB Pharma
6.8.1 UCB Pharma Company Information
6.8.2 UCB Pharma Description and Business Overview
6.8.3 UCB Pharma Mesalazine Enteric Coated Tablets Sales, Revenue and Gross Margin (2019-2024)
6.8.4 UCB Pharma Mesalazine Enteric Coated Tablets Product Portfolio
6.8.5 UCB Pharma Recent Developments/Updates
6.9 CR Sanjiu
6.9.1 CR Sanjiu Company Information
6.9.2 CR Sanjiu Description and Business Overview
6.9.3 CR Sanjiu Mesalazine Enteric Coated Tablets Sales, Revenue and Gross Margin (2019-2024)
6.9.4 CR Sanjiu Mesalazine Enteric Coated Tablets Product Portfolio
6.9.5 CR Sanjiu Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Mesalazine Enteric Coated Tablets Industry Chain Analysis
7.2 Mesalazine Enteric Coated Tablets Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Mesalazine Enteric Coated Tablets Production Mode & Process
7.4 Mesalazine Enteric Coated Tablets Sales and Marketing
7.4.1 Mesalazine Enteric Coated Tablets Sales Channels
7.4.2 Mesalazine Enteric Coated Tablets Distributors
7.5 Mesalazine Enteric Coated Tablets Customers
8 Mesalazine Enteric Coated Tablets Market Dynamics
8.1 Mesalazine Enteric Coated Tablets Industry Trends
8.2 Mesalazine Enteric Coated Tablets Market Drivers
8.3 Mesalazine Enteric Coated Tablets Market Challenges
8.4 Mesalazine Enteric Coated Tablets Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Mesalazine Enteric Coated Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Table 2. Global Mesalazine Enteric Coated Tablets Market Value by Application (2024-2030) & (US$ Million)
 Table 3. Global Mesalazine Enteric Coated Tablets Market Competitive Situation by Manufacturers in 2023
 Table 4. Global Mesalazine Enteric Coated Tablets Sales (Tons) of Key Manufacturers (2019-2024)
 Table 5. Global Mesalazine Enteric Coated Tablets Sales Market Share by Manufacturers (2019-2024)
 Table 6. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Manufacturers (2019-2024)
 Table 7. Global Mesalazine Enteric Coated Tablets Revenue Share by Manufacturers (2019-2024)
 Table 8. Global Market Mesalazine Enteric Coated Tablets Average Price (US$/Ton) of Key Manufacturers (2019-2024)
 Table 9. Global Key Players of Mesalazine Enteric Coated Tablets, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Product Type & Application
 Table 12. Global Key Manufacturers of Mesalazine Enteric Coated Tablets, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Mesalazine Enteric Coated Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine Enteric Coated Tablets as of 2023)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Mesalazine Enteric Coated Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 17. Global Mesalazine Enteric Coated Tablets Sales by Region (2019-2024) & (Tons)
 Table 18. Global Mesalazine Enteric Coated Tablets Sales Market Share by Region (2019-2024)
 Table 19. Global Mesalazine Enteric Coated Tablets Sales by Region (2025-2030) & (Tons)
 Table 20. Global Mesalazine Enteric Coated Tablets Sales Market Share by Region (2025-2030)
 Table 21. Global Mesalazine Enteric Coated Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 22. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2019-2024)
 Table 23. Global Mesalazine Enteric Coated Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 24. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2025-2030)
 Table 25. North America Mesalazine Enteric Coated Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 26. North America Mesalazine Enteric Coated Tablets Sales by Country (2019-2024) & (Tons)
 Table 27. North America Mesalazine Enteric Coated Tablets Sales by Country (2025-2030) & (Tons)
 Table 28. North America Mesalazine Enteric Coated Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 29. North America Mesalazine Enteric Coated Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 30. Europe Mesalazine Enteric Coated Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 31. Europe Mesalazine Enteric Coated Tablets Sales by Country (2019-2024) & (Tons)
 Table 32. Europe Mesalazine Enteric Coated Tablets Sales by Country (2025-2030) & (Tons)
 Table 33. Europe Mesalazine Enteric Coated Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 34. Europe Mesalazine Enteric Coated Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 35. Asia Pacific Mesalazine Enteric Coated Tablets Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 36. Asia Pacific Mesalazine Enteric Coated Tablets Sales by Region (2019-2024) & (Tons)
 Table 37. Asia Pacific Mesalazine Enteric Coated Tablets Sales by Region (2025-2030) & (Tons)
 Table 38. Asia Pacific Mesalazine Enteric Coated Tablets Revenue by Region (2019-2024) & (US$ Million)
 Table 39. Asia Pacific Mesalazine Enteric Coated Tablets Revenue by Region (2025-2030) & (US$ Million)
 Table 40. Latin America Mesalazine Enteric Coated Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 41. Latin America Mesalazine Enteric Coated Tablets Sales by Country (2019-2024) & (Tons)
 Table 42. Latin America Mesalazine Enteric Coated Tablets Sales by Country (2025-2030) & (Tons)
 Table 43. Latin America Mesalazine Enteric Coated Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 44. Latin America Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2019-2024)
 Table 45. Middle East and Africa Mesalazine Enteric Coated Tablets Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
 Table 46. Middle East and Africa Mesalazine Enteric Coated Tablets Sales by Country (2019-2024) & (Tons)
 Table 47. Middle East and Africa Mesalazine Enteric Coated Tablets Sales by Country (2025-2030) & (Tons)
 Table 48. Middle East and Africa Mesalazine Enteric Coated Tablets Revenue by Country (2019-2024) & (US$ Million)
 Table 49. Middle East and Africa Mesalazine Enteric Coated Tablets Revenue by Country (2025-2030) & (US$ Million)
 Table 50. Global Mesalazine Enteric Coated Tablets Sales (Tons) by Type (2019-2024)
 Table 51. Global Mesalazine Enteric Coated Tablets Sales (Tons) by Type (2025-2030)
 Table 52. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2019-2024)
 Table 53. Global Mesalazine Enteric Coated Tablets Sales Market Share by Type (2025-2030)
 Table 54. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Type (2019-2024)
 Table 55. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Type (2025-2030)
 Table 56. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2019-2024)
 Table 57. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Type (2025-2030)
 Table 58. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Type (2019-2024)
 Table 59. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Type (2025-2030)
 Table 60. Global Mesalazine Enteric Coated Tablets Sales (Tons) by Application (2019-2024)
 Table 61. Global Mesalazine Enteric Coated Tablets Sales (Tons) by Application (2025-2030)
 Table 62. Global Mesalazine Enteric Coated Tablets Sales Market Share by Application (2019-2024)
 Table 63. Global Mesalazine Enteric Coated Tablets Sales Market Share by Application (2025-2030)
 Table 64. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Application (2019-2024)
 Table 65. Global Mesalazine Enteric Coated Tablets Revenue (US$ Million) by Application (2025-2030)
 Table 66. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2019-2024)
 Table 67. Global Mesalazine Enteric Coated Tablets Revenue Market Share by Application (2025-2030)
 Table 68. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Application (2019-2024)
 Table 69. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Application (2025-2030)
 Table 70. Dr. Falk Pharma GmbH Company Information
 Table 71. Dr. Falk Pharma GmbH Description and Business Overview
 Table 72. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 73. Dr. Falk Pharma GmbH Mesalazine Enteric Coated Tablets Product
 Table 74. Dr. Falk Pharma GmbH Recent Developments/Updates
 Table 75. Astellas Pharma Inc. Company Information
 Table 76. Astellas Pharma Inc. Description and Business Overview
 Table 77. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 78. Astellas Pharma Inc. Mesalazine Enteric Coated Tablets Product
 Table 79. Astellas Pharma Inc. Recent Developments/Updates
 Table 80. AbbVie Inc. Company Information
 Table 81. AbbVie Inc. Description and Business Overview
 Table 82. AbbVie Inc. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 83. AbbVie Inc. Mesalazine Enteric Coated Tablets Product
 Table 84. AbbVie Inc. Recent Developments/Updates
 Table 85. DSM Pharmaceuticals Company Information
 Table 86. DSM Pharmaceuticals Description and Business Overview
 Table 87. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 88. DSM Pharmaceuticals Mesalazine Enteric Coated Tablets Product
 Table 89. DSM Pharmaceuticals Recent Developments/Updates
 Table 90. Sun Pharmaceutical Industries Ltd. Company Information
 Table 91. Sun Pharmaceutical Industries Ltd. Description and Business Overview
 Table 92. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 93. Sun Pharmaceutical Industries Ltd. Mesalazine Enteric Coated Tablets Product
 Table 94. Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
 Table 95. Fosun Pharma Company Information
 Table 96. Fosun Pharma Description and Business Overview
 Table 97. Fosun Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 98. Fosun Pharma Mesalazine Enteric Coated Tablets Product
 Table 99. Fosun Pharma Recent Developments/Updates
 Table 100. Huahai Pharmaceuticals Company Information
 Table 101. Huahai Pharmaceuticals Description and Business Overview
 Table 102. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 103. Huahai Pharmaceuticals Mesalazine Enteric Coated Tablets Product
 Table 104. Huahai Pharmaceuticals Recent Developments/Updates
 Table 105. UCB Pharma Company Information
 Table 106. UCB Pharma Description and Business Overview
 Table 107. UCB Pharma Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 108. UCB Pharma Mesalazine Enteric Coated Tablets Product
 Table 109. UCB Pharma Recent Developments/Updates
 Table 110. CR Sanjiu Company Information
 Table 111. CR Sanjiu Description and Business Overview
 Table 112. CR Sanjiu Mesalazine Enteric Coated Tablets Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 113. CR Sanjiu Mesalazine Enteric Coated Tablets Product
 Table 114. CR Sanjiu Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Mesalazine Enteric Coated Tablets Distributors List
 Table 118. Mesalazine Enteric Coated Tablets Customers List
 Table 119. Mesalazine Enteric Coated Tablets Market Trends
 Table 120. Mesalazine Enteric Coated Tablets Market Drivers
 Table 121. Mesalazine Enteric Coated Tablets Market Challenges
 Table 122. Mesalazine Enteric Coated Tablets Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Mesalazine Enteric Coated Tablets
 Figure 2. Global Mesalazine Enteric Coated Tablets Market Value Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global Mesalazine Enteric Coated Tablets Market Share by Type: 2023 & 2030
 Figure 4. 0.25g Product Picture
 Figure 5. 0.5g Product Picture
 Figure 6. 1g Product Picture
 Figure 7. Global Mesalazine Enteric Coated Tablets Market Value by Application (2024-2030) & (US$ Million)
 Figure 8. Global Mesalazine Enteric Coated Tablets Market Share by Application: 2023 & 2030
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Others
 Figure 12. Global Mesalazine Enteric Coated Tablets Revenue, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global Mesalazine Enteric Coated Tablets Market Size (2019-2030) & (US$ Million)
 Figure 14. Global Mesalazine Enteric Coated Tablets Sales (2019-2030) & (Tons)
 Figure 15. Global Mesalazine Enteric Coated Tablets Average Price (US$/Ton) & (2019-2030)
 Figure 16. Mesalazine Enteric Coated Tablets Report Years Considered
 Figure 17. Mesalazine Enteric Coated Tablets Sales Share by Manufacturers in 2023
 Figure 18. Global Mesalazine Enteric Coated Tablets Revenue Share by Manufacturers in 2023
 Figure 19. Global 5 and 10 Largest Mesalazine Enteric Coated Tablets Players: Market Share by Revenue in Mesalazine Enteric Coated Tablets in 2023
 Figure 20. Mesalazine Enteric Coated Tablets Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 21. Global Mesalazine Enteric Coated Tablets Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Figure 22. North America Mesalazine Enteric Coated Tablets Sales Market Share by Country (2019-2030)
 Figure 23. North America Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2019-2030)
 Figure 24. United States Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 25. Canada Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 26. Europe Mesalazine Enteric Coated Tablets Sales Market Share by Country (2019-2030)
 Figure 27. Europe Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2019-2030)
 Figure 28. Germany Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 29. France Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 30. U.K. Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 31. Italy Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 32. Russia Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 33. Asia Pacific Mesalazine Enteric Coated Tablets Sales Market Share by Region (2019-2030)
 Figure 34. Asia Pacific Mesalazine Enteric Coated Tablets Revenue Market Share by Region (2019-2030)
 Figure 35. China Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 36. Japan Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 37. South Korea Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 38. India Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 39. Australia Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 40. China Taiwan Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 41. Southeast Asia Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 42. Latin America Mesalazine Enteric Coated Tablets Sales Market Share by Country (2019-2030)
 Figure 43. Mexico Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 44. Brazil Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 45. Argentina Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 46. Colombia Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 47. Middle East and Africa Mesalazine Enteric Coated Tablets Sales Market Share by Country (2019-2030)
 Figure 48. Middle East and Africa Mesalazine Enteric Coated Tablets Revenue Market Share by Country (2019-2030)
 Figure 49. Turkey Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 50. Saudi Arabia Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 51. UAE Mesalazine Enteric Coated Tablets Revenue Growth Rate (2019-2030) & (US$ Million)
 Figure 52. Global Sales Market Share of Mesalazine Enteric Coated Tablets by Type (2019-2030)
 Figure 53. Global Revenue Market Share of Mesalazine Enteric Coated Tablets by Type (2019-2030)
 Figure 54. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Type (2019-2030)
 Figure 55. Global Sales Market Share of Mesalazine Enteric Coated Tablets by Application (2019-2030)
 Figure 56. Global Revenue Market Share of Mesalazine Enteric Coated Tablets by Application (2019-2030)
 Figure 57. Global Mesalazine Enteric Coated Tablets Price (US$/Ton) by Application (2019-2030)
 Figure 58. Mesalazine Enteric Coated Tablets Value Chain
 Figure 59. Mesalazine Enteric Coated Tablets Production Process
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart